|
|
||||||||
1 Division of Cardiovascular Medicine, University of California, Davis 95616; Department of Veteran Affairs, Northern California Health Care System, Mather 95655; and 2 Division of Cardiology, San Francisco General Hospital, San Francisco, California 94110
| |
ABSTRACT |
|---|
|
|
|---|
Prolonged myocardial ischemia results in an increase in intracellular calcium concentration ([Ca2+]i), which is thought to play a critical role in ischemia-reperfusion injury. Ischemic preconditioning (PC) improves myocardial function during ischemia-reperfusion, a process that may involve opening mitochondrial ATP-sensitive potassium (KATP) channels. Because pharmacological limitation of mitochondrial calcium concentration ([Ca2+]m) overload during ischemia-reperfusion has been shown to improve myocardial function, we hypothesized that PC would reduce [Ca2+]m during ischemia-reperfusion and that this effect was mediated by opening mitochondrial KATP channels. Isolated rat hearts were subjected to 25 min of global ischemia and 30 min of reperfusion with or without PC in the presence of mitochondrial KATP channel opening (diazoxide, 100 µM) and blockade [5-hydroxydecanoic acid (5-HD), 100 µM]. Contracture during ischemia (end-diastolic pressure) and functional recovery on reperfusion (developed pressure) were assessed. Total [Ca2+]i and [Ca2+]m were measured using indo 1 fluorescence. Both PC and diazoxide limited the increase in end-diastolic pressure and resulted in greater functional recovery after 30 min of reperfusion, functional effects that were partially or completely abolished by 5-HD. PC and diazoxide also significantly limited the increase in [Ca2+]m during ischemia-reperfusion. In addition, PC lowered [Ca2+]i during reperfusion, whereas diazoxide paradoxically resulted in increased [Ca2+]i during reperfusion. There was an inverse linear relationship between [Ca2+]m and developed pressure during reperfusion. PC limits the ischemia-induced increase in mitochondrial, but not total, [Ca2+]i, an effect mediated by opening mitochondrial KATP channels. These data suggest that the lowering of mitochondrial calcium overload is a mechanism of cardioprotection in PC.
ischemia; reperfusion; mitochondria; calcium
| |
INTRODUCTION |
|---|
|
|
|---|
ISCHEMIC PRECONDITIONING (PC) is a phenomenon in which a single period or multiple brief periods of ischemia have been shown to protect the heart against a more prolonged ischemic insult (7, 30, 37). Although it has been proposed that a number of substances and signaling pathways may be involved in mediating the cardioprotective effect of PC (7, 37), the precise mechanism by which PC exerts its protective effects is not known. Recent studies have focused on the potential role of mitochondrial ATP-sensitive potassium (KATP) channels as the effectors of protection in PC (13).
Opening of mitochondrial KATP channels has been shown to protect the heart during ischemia-reperfusion (11, 14), although the mechanism of this protection is largely unknown. One hypothesis proposed is that opening the mitochondrial KATP channel dissipates the inner mitochondrial membrane potential established by the proton pump (26). This dissipation is expected to reduce the driving force for Ca2+ influx through the Ca2+ uniporter, thus attenuating mitochondrial calcium concentration ([Ca2+]m) overload (8-10). This postulate has been supported in a recent study using isolated rat mitochondria and intact rat cardiomyocytes in which KATP channel openers prevented [Ca2+]m overload by both reducing the driving force for Ca2+ uptake via the uniporter and by activating cyclosporin-sensitive Ca2+ efflux (20).
[Ca2+]m overload has been closely correlated with mitochondrial and myocardial damage and cell death (5, 8, 18, 27, 28, 32). Although limiting [Ca2+]m overload is expected to contribute to cardioprotection, direct evidence that opening mitochondrial KATP channel limits ischemia-induced [Ca2+]m overload is lacking.
Recent fluorescent techniques allow the measurement of total intracellular calcium concentration ([Ca2+]i) and [Ca2+]m in beating, perfused hearts by using the calcium indicator indo 1 and cytosolic calcium quenching using manganese (3, 4, 34). With the use of this methodology, Miyamae et al. (27) have shown that pharmacological limitation of [Ca2+]m overload resulted in greater functional recovery after ischemia-reperfusion. These findings, in the face of no change in cytosolic calcium concentration ([Ca2+]c), suggest that limiting [Ca2+]m overload is protective independent of [Ca2+]c.
Thus the purpose of this study was to test the hypotheses that 1) PC limits the accumulation of [Ca2+]m during ischemia and reperfusion, and 2) this effect is mediated by opening mitochondrial KATP channels. These experiments used the fluorescence indicator indo 1 to measure [Ca2+]i and [Ca2+]m in isolated, perfused hearts with parallel measurement of hemodynamics. The role of mitochondrial KATP was elucidated using the mitochondrial KATP channel opener diazoxide and the mitochondrial KATP channel blocker 5-hydroxydecanoic acid (5-HD).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Heart Perfusion and Measurements of Function
Male Sprague-Dawley rats (300-350 g) were administered heparin (100 units ip) and anesthetized with pentobarbital sodium (65 mg/kg ip). As soon as deep anesthesia was achieved, evidenced by lack of eye-blink reflex and foot withdrawal reflex, hearts were rapidly isolated and retrograde perfused with a modified Krebs-Henseleit buffer containing the following (in mM): 118 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 CaCl2, 25 NaHCO3, and 11 glucose. The hearts were not paced, and perfusion pressure was set at 100 cmH2O. The perfusion apparatus was temperature controlled with heated baths used for the perfusate and a water jacketing around the perfusion tubing to maintain heart temperature at 37 ± 0.05°C under all conditions. A gas mixture of 95% O2-5% CO2 was directly bubbled in the perfusate containers. Left ventricular end-diastolic pressure (LVEDP) and systolic pressure were measured throughout the protocols via a H2O-filled latex balloon inserted into the left ventricle. Hemodynamic data were obtained using a computer-based physiological recording system (Biopac Systems; Santa Barbara, CA).Fluorescence Measurements
Fluorescence instrumentation. Fluorescence measurements were performed as previously described in detail (3, 4) using a modified spectrofluorometer (model SLM8100, SLM Instruments; Rochester, NY). Excitation light from a 450-W xenon arc lamp (Ushio) was filtered through a 350-nm interference filter and focused onto the ingoing leg of a quartz bifurcated fiber bundle (Dolan-Jenner Industries; Lawrence, MA). The common leg of this 1.57-mm diameter fiber bundle was girdled against the epicardial surface of the left ventricle, avoiding visible vessels. A shutter in front of the excitation light was opened for only seconds at a time during data acquisition to prevent bleaching of the indo 1 fluorescence. The fluorescence signal was transferred via the outgoing leg of the bundle and separated by 385- and 456-nm interference filters before detection by photomultiplier tubes.
Indo 1 acetoxymethyl ester loading. After a 15-min equilibration period, baseline background fluorescence [primarily NADH (3, 4)] was measured and subtracted from all subsequent fluorescence measurements. Hearts were then loaded for 25 min by retrograde perfusion with Krebs-Henseleit buffer containing indo 1, acetoxymethyl ester (indo 1-AM; 6 µM, dissolved in dimethyl sulfoxide and Pluronic F-127, 20% wt/vol, Molecular Probes; Johnston City, OR) and fetal bovine serum (1%). Probenecid (0.1 mM, Sigma; St. Louis, MO) was added to all perfusates to slow the extrusion of indo 1 from the myocytes (1). Residual indo 1-AM was washed out by perfusing with standard buffer for 25 min. An experiment was discarded if the fluorescent intensity at either 385 or 456 nm was less than twice the background fluorescence during any phase of the experimental protocol.
Experimental Protocols
Hearts were randomly assigned to one of five groups described below (n = 5 in each group). All hearts had a 15-min equilibration period with baseline measurements of LVEDP, systolic pressure, and background fluorescence. Loading of indo 1-AM was followed by a 25-min washout period. Control hearts then had a 50-min period of normal perfusion before 25 min of no-flow ischemia and 30 min of reperfusion. PC hearts had four PC episodes (5-min ischemia and 5-min reperfusion) followed by 10 min of normal perfusion before ischemia. The effects of mitochondrial KATP channel blockade on PC were examined by perfusing with 5-HD (100 µM) for 10 min before PC (PC + 5-HD). The effects of pharmacological mitochondrial KATP channel opening were determined by adding diazoxide (100 µM) to the perfusate for 10 min before ischemia with or without 5-HD (100 µM) (diazoxide and diazoxide + 5-HD). Drug concentrations used in this study are active in the perfused rat heart model (12). [Ca2+]i and [Ca2+]m were measured separately in parallel experiments. Hemodynamic and indo 1 fluorescence intensity measurements were repeated every 5 min.Mn2+ quenching of cytosolic fluorescence. To determine mitochondrial fluorescence, cytosolic fluorescence was quenched by adding MnCl2 at a final concentration of 17.5 µM to the perfusate 10 min before the 25-min ischemic period. Adequate quenching was verified by the loss of calcium transients after manganese loading. The addition of MnCl2 did not alter cardiac function (heart rate or developed pressure).
Calculations
Calculation of [Ca2+]i.
[Ca2+]i was calculated using
the standard equation for fluorescent calcium indicators
(15)
|
Calculation of [Ca2+]m. [Ca2+]m was calculated using the same equation employed to calculate total [Ca2+]i from the fluorescent intensity after manganese quenching. On the basis of prior studies (28, 29, 35), the calibration parameters were assumed to be the same in the cytosolic and mitochondrial compartments.
The above calculations, the results of which are presented in Tables 1 and 2, do not take into account the confounding issues of NADH autofluorescence, leak of indo 1 into the extracellular space, or the effect of manganese quenching on extracellular calcium or mitochondrial calcium during myocardial ischemia. Experiments were undertaken to semiquantitatively assess these effects and determine whether these issues would alter the findings of the study.
|
|
NADH autofluorescence. NADH is known to increase during ischemia, thus increasing the background fluorescence signal. Although it was not possible to simultaneously measure NADH and indo 1 fluorescence in each individual heart, NADH fluorescence was measured in parallel experiments in all groups. The change in NADH fluorescence was similar between groups, increasing minimally at 385 nm but doubling at 456 nm and remaining stable during the entire ischemic period. The NADH signal rapidly returned to baseline levels on reperfusion. Thus, whereas [Ca2+] might be underestimated due to these changes in NADH after the induction of ischemia, the relative changes should be similar. These experiments also demonstrated that high concentrations of NADH suppressed both excitation and emission light intensities, thus tending to reduce indo 1 fluorescence during ischemia.
Indo 1 leak during ischemia. Loss of membrane integrity could result in the loss of indo 1 during ischemia and reperfusion, yielding both lower intracellular signal intensity as well as providing a signal related to the high extracellular [Ca2+] in the perfusate. We measured the amount of indo 1 loss during the initial period of reperfusion and found similar degrees of leakage between groups.
Manganese quenching of indo 1.
Because the manganese quench was applied before the onset of
ischemia, two issues relating to this procedure arise. First, the extracellular manganese concentration of 17.5 µM is insufficient to fully quench the indo 1 signal at the high (1.2 mM) calcium concentration in the perfusate. In vitro experiments demonstrated that
only ~50% of the indo 1 signal was quenched using this concentration of manganese. Second, there is likely leakage of manganese into the
mitochondria during ischemia (21, 22), resulting
in some quenching of the mitochondrial indo 1 signal. In general, this would result in a loss of the signal-to-noise ratio but no change in
the calculated [Ca2+]m, because the
fluorescence ratio is used to calculate the concentration. However,
differential quenching at different leak amounts could bias the data.
Therefore, in vitro experiments were performed at varying
concentrations of manganese at a pathophysiological but representative
[Ca2+] (500 nM). These experiments demonstrated there was
no dose effect of manganese on the fluorescent ratio and, hence,
calculated [Ca2+] (Fig. 1).
|
Statistical Analysis
Data presented are means ± SE. Differences in data between groups were analyzed using ANOVA. Student-Neuman-Keuls post-test was used if the ANOVA was significant. A value of P < 0.05 was considered statistically significant.| |
RESULTS |
|---|
|
|
|---|
Hemodynamics
Diazoxide and 5-HD had little effect on left ventricular developed pressure (LVDP) and LVEDP before ischemia. After ischemia and 30 min of reperfusion, LVDP was significantly greater in diazoxide-treated and PC hearts than in control hearts (Fig. 2A). During the reperfusion period, LVEDP was elevated in control hearts, whereas both diazoxide and PC significantly reduced LVEDP during reperfusion (Fig. 2B). The effects of diazoxide and PC on LVDP and LVEDP were partially or completely abolished by 5-HD (Fig. 2).
|
[Ca2+]i
[Ca2+]i versus time for all groups are shown in Table 1 and Fig. 3. [Ca2+]i in control hearts increased steadily during 25 min of ischemia and reached an average concentration of 650 nM at the end of ischemia. The increase in [Ca2+]i was similar in other groups with the exception of hearts treated with diazoxide, which had higher [Ca2+]i after 25 min of ischemia. [Ca2+]i in control hearts increased further during the first 20 min of reperfusion and then fell, but did not return to preischemic levels after 30 min of reperfusion. PC abolished the increase in [Ca2+]i during reperfusion, resulting in significantly lower [Ca2+]i than in control hearts. In contrast, [Ca2+]i increased during reperfusion in the diazoxide-treated hearts (Fig. 3A). 5-HD reversed the effects of both diazoxide and PC on [Ca2+]i (Fig. 3B).
|
[Ca2+]m
[Ca2+]m was identical in all groups before the initiation of ischemia (Table 2). However, the increase in [Ca2+]m was significantly lower in both diazoxide-treated and PC hearts than in control hearts during 25 min of ischemia and 30 min of reperfusion (Table 2 and Fig. 4A). These differences occurred early in the ischemic period (10 min). 5-HD abolished the effects of both diazoxide and PC in limiting mitochondrial Ca2+ overload during ischemia and in the early reperfusion period. However, control hearts still had higher [Ca2+]m in the last 15 min of reperfusion compared with the 5-HD-treated hearts (Table 2 and Fig. 4B).
|
Relationship of [Ca2+] to Functional Recovery
The absence of functional recovery in most of the control and diazoxide + 5-HD-treated hearts precluded quantitative assessment of the relationship of [Ca2+] to functional recovery in these groups. Functional recovery defined by the LVDP after 30 min of reperfusion was inversely related to [Ca2+]m. As seen in Fig. 5, there was a linear relationship across the PC, PC + 5-HD, and diazoxide groups, with >50% recovery only seen in those hearts (PC and diazoxide) with [Ca2+]m below 750 nM. These results parallel those of Miyamae et al. (27).
|
| |
DISCUSSION |
|---|
|
|
|---|
Previous studies using isolated rat hearts have shown that the cardioprotective effect of PC is due in part to opening of mitochondrial KATP channels and that diazoxide, a mitochondrial KATP channel opener, mimics PC (11, 12, 26). However, the mechanism of this effect is unknown. This study shows that opening mitochondrial KATP channels by either PC or a KATP channel opener can reduce mitochondrial calcium overload during ischemia and reperfusion in isolated rat hearts. Although the reduction in [Ca2+]m was associated with greater recovery of LVDP, the protective effect was independent of total [Ca2+]i. These data are consistent with the hypothesis that opening mitochondrial KATP channels, either pharmacologically or by PC, limits mitochondrial Ca2+ overload during ischemia and reperfusion.
[Ca2+]m Overload and Ischemia-Reperfusion Injury
These experiments validate that mitochondrial Ca2+ accumulates during and after ischemia. Mitochondria have distinct pathways for Ca2+ influx and efflux (17). Under normoxic conditions, uptake of Ca2+ occurs predominantly by a uniporter and is driven by the mitochondrial membrane potential (17). Ca2+ efflux occurs principally via the Na+/Ca2+ antiporter, the maximum capacity of which is roughly one-tenth that of influx via the uniporter. Another regulatory pathway is referred to as the mitochondrial permeability transition pore (16). Opening of this pore can result from massive mitochondrial calcium overload (24), causing mitochondria to become uncoupled and the proton-translocating ATPase to turn from synthesizing ATP to actively hydrolyzing ATP, eventually resulting in cell death.Prior studies have indicated that reperfusion/reoxygenation injury correlates well with [Ca2+]m uptake, although there is no correlation with [Ca2+]i (27, 28). In Miyamae et al. (27), [Ca2+]m was measured by Mn2+ quenching 20 min into reperfusion with and without exposure to ruthenium red to block entry of Ca2+ into the mitochondria. This study found that functional recovery was greater in hearts exposed to ruthenium red, was inversely correlated with [Ca2+]m, but was independent of [Ca2+]c (which was unaffected by blockade of mitochondrial calcium entry). These findings were consistent with a critical role of pharmacological limitation of [Ca2+]m during reperfusion after ischemia, but did not address whether endogenous limitation of [Ca2+]m occurred during ischemia.
In parallel with pharmacological inhibition of mitochondrial Ca2+ entry with ruthenium red (27), the current findings indicate that both PC and KATP channel opening with diazoxide limit [Ca2+]m during ischemia as well as reperfusion in parallel with greater functional recovery. As in the prior study (27), the degree of functional recovery was linearly and inversely related to [Ca2+]m below a threshold level (Fig. 5). This may represent a threshold value of [Ca2+]m above which mitochondria cannot function or, possibly, varying proportions of [Ca2+]m values from populations of mitochondria that have normal or lethal calcium concentrations.
The Role of Mitochondrial KATP Channels
Recent studies suggest that the cardioprotective effects induced by the mitochondrial KATP channel opener diazoxide and PC are due to preservation of mitochondrial function (11, 23). It has been proposed that mitochondrial KATP channel openers, by virtue of their ability to dissipate the mitochondrial membrane potential (6, 19), may reduce the driving force for Ca2+ accumulation (25). Recently, Holmuhamedov et al. (20) showed, at the level of isolated mitochondria as well as in intact cardiomyocytes, that KATP channel openers not only impede mitochondrial Ca2+ uptake but also promote mitochondrial Ca2+ release, thereby diminishing the amount of accumulated Ca2+ within the mitochondrial matrix. In the current study, diazoxide, a selective mitochondrial KATP channel opener, reduced [Ca2+]m overload during ischemia and reperfusion, which was abolished by the mitochondrial KATP channel-selective blocker 5-HD.Previous studies suggest that PC-induced cardioprotection is mediated via activation of mitochondrial KATP channels (12, 25). Recently, Fryer et al. (11) examined the role of mitochondrial KATP channels in a rat model of PC and demonstrated that inhibition of the mitochondrial KATP channel attenuated cardioprotection induced by PC. The present study provides further evidence that PC-induced cardioprotection is indeed mediated by opening of the mitochondrial KATP channel in the isolated rat heart because cardioprotection was abolished by the mitochondrial KATP channel-selective blocker 5-HD. More importantly, PC-induced opening of mitochondrial KATP channels limited [Ca2+]m overload. These data are consistent with the previous hypothesis that PC-induced opening of the mitochondrial KATP channel would reduce [Ca2+]m overload (25). As has been proposed, the mitochondrial membrane potential may play an important role in this process. Recently, Ylitalo et al. (38) showed that the decrease in the mitochondrial membrane potential during prolonged ischemia was more rapid in preconditioned hearts. On the basis of these data, we can speculate that lower [Ca2+]m in the preconditioned hearts resulted, at least in part, from a decrease in the driving force for Ca2+ entering mitochondria through the Ca2+ uniporter.
Although the current results do not indicate whether lower [Ca2+]m during ischemia and reperfusion was directly responsible for the cardioprotective effect of the mitochondrial KATP channel opener and PC, previous studies (27) with Ca2+-uniporter blockers suggest this is likely an important component of cardioprotection. By assessing mitochondrial Ca2+ and the functional recovery in isolated rat hearts, this study provides a link between ischemia-reperfusion injury, [Ca2+]m overload, and mitochondrial KATP channel activation.
Mitochondrial Versus Cellular Calcium Overload
It is interesting to note that, although diazoxide and PC had a profound effect on mitochondrial Ca2+, PC did not limit the accumulation of [Ca2+]i during ischemia and diazoxide-treated hearts had even higher end-ischemic [Ca2+]i than control hearts. Even more noteworthy, [Ca2+]i in PC hearts was significantly lower than in control hearts after 30 min of reperfusion, whereas [Ca2+]i in the diazoxide-treated group was higher than control. Thus there was a dissociation between functional recovery (seen in both groups) and lower [Ca2+]i, (seen only in the PC hearts). These data parallel the findings of Miyamae et al. (27), who found that recovery of ischemic-reperfused hearts was dependent on lower [Ca2+]m but was independent of [Ca2+]i.The role of lower [Ca2+]i in the PC hearts and the mechanism of this observation is only speculative. It is unclear whether the limitation of [Ca2+]i was a primary effect of PC or, more likely, a secondary effect of improved mitochondrial function resulting in greater ATP production and, hence, sarcolemmal Ca-ATPase function (10). Alternatively, other mechanisms of PC, such as preservation of sarcoplasmic reticulum (SR) function, may play a role in regulating [Ca2+]i. Investigators (31, 36) have reported that SR Ca2+ release and Ca2+ uptake activity was relatively preserved in PC hearts after reperfusion, an effect that may result in greater SR accumulation of calcium and lower cytosolic calcium. Another factor that may affect intracellular calcium in PC hearts is the rapid reduction in intracellular sodium observed during reperfusion (33), an event that would alter the kinetics of Na+/Ca2+ exchange across the sarcolemma and limit [Ca2+]i. In contrast, the pharmacological opening of mitochondrial KATP channels with diazoxide would not be expected to produce these ancillary effects of PC and, by limiting mitochondrial Ca2+ accumulation, result in higher [Ca2+]i.
These data suggest that elevation of the intracellular level of
[Ca2+]i may not be necessarily pathological
when the mitochondrial level of [Ca2+]m is
limited. This may occur because a critical element in determining cellular recovery and the return of ion homeostasis on reperfusion is
the ability of the cell to synthesize ATP and maintain the free energy
of hydrolysis (
G) above a critical level.
Limitations
In contrast to other techniques, the use of indo 1 calcium fluorescence has distinct advantages with minimal effects on contractility, excellent time resolution, and the ability to identify [Ca2+]m (3, 4, 27-29, 34). However, certain limitations to this technique must be considered, as noted in MATERIALS AND METHODS. We have considered these potential confounding factors and provide evidence that the effects of NADH autofluorescence, indo 1 leakage, and manganese quenching are similar in all groups. Thus, although the absolute values of [Ca2+] may not be exact, the data suggest that the relative measurements of [Ca2+] are valid.The present study has shown that PC and diazoxide each protect the myocardium against ischemia-reperfusion injury and enhance the recovery of postischemic contractile function. The mechanism underlying this cardioprotective effect of diazoxide and PC may be attributed to limiting mitochondrial, but not intracellular, Ca2+ overload during ischemia and reperfusion by opening mitochondrial KATP channels.
| |
ACKNOWLEDGEMENTS |
|---|
This research was supported by a Veterans Administration Merit Review grant (to S. Schaefer) and by a National Institutes of Health grant (to S. A. Camacho)
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: S. Schaefer, Division of Cardiovascular Medicine, One Shields Ave., TB 172, Bioletti Way, University of California at Davis, Davis, CA 95616 (E-mail: sschaefer{at}ucdavis.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 30 August 2000; accepted in final form 4 January 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Arkhammar, P,
Nilsson T,
and
Berggren P.
Glucose-stimulated efflux of indo 1 from pancreatic beta-cells is reduced by probenecid.
FEBS Lett
273:
182-184,
1990[Web of Science][Medline].
2.
Baker, AJ,
Brandes R,
Schreur JHM,
Camacho SA,
and
Weiner MW.
Protein and acidosis alter calcium-binding and fluorescence spectra of the calcium indicator indo 1.
Biophys J
67:
1646-1654,
1994[Web of Science][Medline].
3.
Brandes, R,
Figueredo VM,
Camacho SA,
Baker AJ,
and
Weiner MW.
Quantitation of cytosolic [Ca2+] in whole perfused rat hearts using indo 1 fluorometry.
Biophys J
65:
1973-1982,
1993[Web of Science][Medline].
4.
Brandes, R,
Figueredo VM,
Camacho SA,
Baker AJ,
and
Weiner MW.
Investigation of factors affecting fluorometric [Ca2+]c quantitation in perfused heart.
Biophys J
65:
1983-1993,
1993[Web of Science][Medline].
5.
Buja, LM.
Modulation of the myocardial response to ischemia.
Lab Invest
78:
1345-1373,
1998[Web of Science][Medline].
6.
Czyz, A,
Szewczyk A,
Nalecz MJ,
and
Wojtczak L.
The role of mitochondrial potassium fluxes in controlling the protonmotive force in energized mitochondria.
Biochem Biophys Res Commun
210:
98-104,
1995[Web of Science][Medline].
7.
Dekker, LRC
Toward the heart of ischemic preconditioning.
Cardiovasc Res
37:
14-21,
1998
8.
Di Lisa, F,
and
Bernardi P.
Mitochondrial function as a determinant of recovery or death in cell response to injury.
Mol Cell Biochem
184:
379-391,
1998[Web of Science][Medline].
9.
Di Lisa, F,
Menabo R,
Canton M,
and
Petronilli V.
The role of mitochondria in the salvage and the injury of the ischemic myocardium.
Biochim Biophys Acta
1366:
69-78,
1998[Medline].
10.
Ferrari, R.
The role of mitochondria in ischemic heart disease.
J Cardiovasc Pharmacol
28:
S1-S10,
1996.
11.
Fryer, RM,
Eells JT,
Hsu AK,
Henry MM,
and
Gross GJ.
Ischemic preconditioning in rats: role of mitochondrial KATP channel in preservation of mitochondrial function.
Am J Physiol Heart Circ Physiol
278:
H305-H312,
2000
12.
Garlid, GJ,
Paucek P,
Yarov-Yarovoy V,
Murray HN,
Darbenzio RB,
D'Alonzo AJ,
Lodge NJ,
Smith MA,
and
Grover GJ.
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: possible mechanisms of protection.
Circ Res
81:
1072-1082,
1997
13.
Gross, GJ,
and
Fryer RM.
Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning.
Circ Res
84:
973-979,
1999
14.
Grover, GJ.
Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion.
Can J Physiol Pharmacol
75:
309-315,
1997[Web of Science][Medline].
15.
Grynkiewicz, G,
Poenie M,
and
Tsien RY.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:
3440-3450,
1985
16.
Gunter, TE,
Gunter KK,
Sheu SS,
and
Gavin CE.
Mitochondrial calcium transport: physiological and pathological relevance.
Am J Physiol Cell Physiol
267:
C313-C339,
1994
17.
Gunter, TE,
and
Pfeiffer DR.
Mechanisms by which mitochondria transport calcium.
Am J Physiol Cell Physiol
258:
C755-C786,
1990
18.
Hardy, L,
Clark JB,
Darley-Usmar V,
Smith DR,
and
Stone D.
Reoxygenation-dependent decrease in mitochondrial NADH: CoQ reductase (complex I) activity in the hypoxic/reoxygenated rat heart.
Biochem J
274:
133-137,
1991.
19.
Holmuhamedov, EL,
Jovanovic S,
Dzeja PP,
Jovanovic A,
and
Terzic A.
Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function.
Am J Physiol Heart Circ Physiol
275:
H1567-H1576,
1998
20.
Holmuhamedov, EL,
Wang L,
and
Terzic A.
ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria.
J Physiol (Lond)
519:
347-360,
1999
21.
Hunter, D,
Haworth RA,
and
Berkoff H.
Cellular manganese uptake by the isolated perfused rat heart.
J Mol Cell Cardiol
13:
823-832,
1981[Web of Science][Medline].
22.
Hunter, D,
Komai H,
Haworth R,
Jackson M,
and
Berkoff H.
Comparison of Ca2+, Sr2+, and Mn2+ fluxes in mitochondria of the perfused rat heart.
Circ Res
47:
721-727,
1980
23.
Iwai, T,
Tanonaka K,
Koshimizu M,
and
Takeo S.
Preservation of mitochondrial function by diazoxide during sustained ischaemia in the rat heart.
Br J Pharmacol
129:
1219-1227,
2000[Web of Science][Medline].
24.
Lehninger, A.
Mitochondria and calcium ion transport.
Biochem J
119:
129-138,
1970[Medline].
25.
Liu, Y,
Sato T,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?
Circulation
97:
2463-2469,
1998
26.
Liu, Y,
Sato T,
Seharaseyson J,
Szewczyk A,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-dependent potassium channels. Viable candidate effectors of ischemic preconditioning.
Ann NY Acad Sci
874:
27-37,
1999[Web of Science][Medline].
27.
Miyamae, M,
Camacho SA,
and
Weiner MW.
Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts.
Am J Physiol Heart Circ Physiol
271:
H2145-H2153,
1996
28.
Miyata, H,
Lakatta EG,
Stern MD,
and
Silverman HS.
Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia.
Circ Res
71:
605-613,
1992
29.
Miyata, H,
Silverman HS,
Sollott SJ,
Lakatta EG,
Stern MD,
and
Hansford RG.
Measurement of mitochondrial free Ca2+ concentration in single living rat cardiac myocytes.
Am J Physiol Heart Circ Physiol
261:
H1123-H1134,
1991
30.
Murry, CE,
Jennings RB,
and
Reimer KA.
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Circulation
74:
1124-1136,
1986
31.
Osada, M,
Netticadan T,
Tamura K,
and
Dhalla NS.
Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning.
Am J Physiol Heart Circ Physiol
274:
H2025-H2034,
1998
32.
Piot, CA,
Padmanaban D,
Ursell PC,
Sievers RE,
and
Wolfe CL.
Ischemic preconditioning decreases apoptosis in rat hearts in vivo.
Circulation
96:
1598-1604,
1997
33.
Ramasamy, R,
Liu H,
Lundmark JL,
Anderson S,
and
Schaefer S.
Ischemic preconditioning stimulates sodium and proton transport in the isolated rat heart.
J Clin Invest
96:
1464-1472,
1995.
34.
Schreur, JH,
Figueredo VM,
Miyamae M,
Shames DM,
Baker AJ,
and
Camacho SA.
Cytosolic and mitochondrial [Ca2+] in whole hearts using indo 1 acetoxymethyl ester: effects of high extracellular Ca2+.
Biophys J
70:
2571-2580,
1996[Web of Science][Medline].
35.
Spurgeon, HA,
Stern MD,
Baartz G,
Raffaeli S,
Hansford RG,
Talo A,
Lakatta EG,
and
Capogrossi MC.
Simultaneous measurement of Ca2+, contraction, and potential in cardiac myocytes.
Am J Physiol Heart Circ Physiol
258:
H574-H586,
1990
36.
Tani, M,
Asakura Y,
Hasegawa H,
Shinmura K,
Ebihara Y,
and
Nakamura Y.
Effect of preconditioning on ryanodine-sensitive Ca2+ release from sarcoplasmic reticulum of rat heart.
Am J Physiol Heart Circ Physiol
271:
H876-H881,
1996
37.
Yellon, DM,
Baxter GF,
Garcia-Dorado D,
Heusch G,
and
Sumeray MS.
Ischemic preconditioning: present position and future directions.
Cardiovasc Res
37:
21-33,
1998
38.
Ylitalo, K,
Ala-Rami A,
Liimatta E,
Peuhkurinen K,
and
Hassinen IE.
Intracellular free calcium and mitochondrial membrane potential in ischemia/reperfusion and preconditioning.
J Mol Cell Cardiol
32:
1223-1238,
2000[Web of Science][Medline].
This article has been cited by other articles:
![]() |
L. Bautista, M. J. Castro, J. Lopez-Barneo, and A. Castellano Hypoxia Inducible Factor-2{alpha} Stabilization and Maxi-K+ Channel {beta}1-Subunit Gene Repression by Hypoxia in Cardiac Myocytes: Role in Preconditioning Circ. Res., June 19, 2009; 104(12): 1364 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishii, T. Amano, T. Matsubara, and T. Murohara Pharmacological Intervention for Prevention of Left Ventricular Remodeling and Improving Prognosis in Myocardial Infarction Circulation, December 16, 2008; 118(25): 2710 - 2718. [Full Text] [PDF] |
||||
![]() |
M. E. Pamenter, D. S.-H. Shin, M. Cooray, and L. T. Buck Mitochondrial ATP-sensitive K+ channels regulate NMDAR activity in the cortex of the anoxic western painted turtle J. Physiol., February 15, 2008; 586(4): 1043 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Argaud, O. Gateau-Roesch, L. Augeul, E. Couture-Lepetit, J. Loufouat, L. Gomez, D. Robert, and M. Ovize Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H386 - H391. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Birkenmeier, A. Staudt, W.-H. Schunck, I. Janke, C. Labitzke, T. Prange, C. Trimpert, T. Krieg, M. Landsberger, V. Stangl, et al. COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2148 - H2154. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Deyhimy, N. W. Fleming, I. G. Brodkin, and H. Liu Anesthetic Preconditioning Combined with Postconditioning Offers No Additional Benefit Over Preconditioning or Postconditioning Alone Anesth. Analg., August 1, 2007; 105(2): 316 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gao, L. Chen, and H.-T. Yang Activation of {alpha}1B-adrenoceptors alleviates ischemia/reperfusion injury by limitation of mitochondrial Ca2+ overload in cardiomyocytes Cardiovasc Res, August 1, 2007; 75(3): 584 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lutz and H. Liu Inhaled sevoflurane produces better delayed myocardial protection at 48 versus 24 hours after exposure. Anesth. Analg., April 1, 2006; 102(4): 984 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hassouna, M. Loubani, B. M. Matata, A. Fowler, N. B. Standen, and M. Galinanes Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium Cardiovasc Res, February 1, 2006; 69(2): 450 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, L. Wang, M. Eaton, and S. Schaefer Sevoflurane Preconditioning Limits Intracellular/Mitochondrial Ca2+ in Ischemic Newborn Myocardium Anesth. Analg., August 1, 2005; 101(2): 349 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishizawa, P. E. Wolkowicz, T. Yamagishi, L.-L. Guo, and M. M. Pike Fasudil prevents KATP channel-induced improvement in postischemic functional recovery Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H3011 - H3015. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Gursahani and S. Schaefer Acidification reduces mitochondrial calcium uptake in rat cardiac mitochondria Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2659 - H2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Xu, J. Wang, R. Kodavatiganti, Y. Zeng, and I. S. Kass Activation of Protein Kinase C Contributes to the Isoflurane-Induced Improvement of Functional and Metabolic Recovery in Isolated Ischemic Rat Hearts Anesth. Analg., October 1, 2004; 99(4): 993 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hausenloy, D. M. Yellon, S. Mani-Babu, and M. R. Duchen Preconditioning protects by inhibiting the mitochondrial permeability transition Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H841 - H849. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz and G. Heusch Connexin 43 and ischemic preconditioning Cardiovasc Res, May 1, 2004; 62(2): 335 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O'Rourke Evidence for Mitochondrial K+ Channels and Their Role in Cardioprotection Circ. Res., March 5, 2004; 94(4): 420 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gross and J. N. Peart KATP channels and myocardial preconditioning: an update Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H921 - H930. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Rajesh, S. Sasaguri, Z. Zhitian, R. Suzuki, R. Asakai, and H. Maeda Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression Cardiovasc Res, August 1, 2003; 59(2): 297 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Clark, P. Naughton, S. Shurey, C. J. Green, T. R. Johnson, B. E. Mann, R. Foresti, and R. Motterlini Cardioprotective Actions by a Water-Soluble Carbon Monoxide-Releasing Molecule Circ. Res., July 25, 2003; 93 (2): e2 - e8. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Uchiyama, H. Otani, T. Okada, T. Uchiyama, H. Ninomiya, M. Kido, H. Imamura, S. Nakao, and K. Shingu Integrated pharmacological preconditioning in combination with adenosine, a mitochondrial KATP channel opener and a nitric oxide donor J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 148 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. D'Souza, D. M. Yellon, C. Martin, R. Schulz, G. Heusch, A. Onody, P. Ferdinandy, and G. F. Baxter B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1592 - H1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xu, Y. Liu, S. Wang, T. McDonald, J. E. Van Eyk, A. Sidor, and B. O'Rourke Cytoprotective Role of Ca2+- Activated K+ Channels in the Cardiac Inner Mitochondrial Membrane Science, November 1, 2002; 298(5595): 1029 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J Hausenloy, H. L Maddock, G. F Baxter, and D. M Yellon Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res, August 15, 2002; 55(3): 534 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Han, N. Kim, H. Joo, and E. Kim Ketamine abolishes ischemic preconditioning through inhibition of KATP channels in rabbit hearts Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H13 - H21. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dos Santos, A. J. Kowaltowski, M. N. Laclau, S. Seetharaman, P. Paucek, S. Boudina, J.-B. Thambo, L. Tariosse, and K. D. Garlid Mechanisms by which opening the mitochondrial ATP- sensitive K+ channel protects the ischemic heart Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H284 - H295. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, A. K. S. Camara, J. An, M. L. Riess, E. Novalija, and D. F. Stowe Cardiac preconditioning with 4-h, 17{degrees}C ischemia reduces [Ca2+]i load and damage in part via KATP channel opening Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1961 - H1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, M. V Cohen, M. Behrends, J. M Downey, and G. Heusch Signal transduction of ischemic preconditioning Cardiovasc Res, November 1, 2001; 52(2): 181 - 198. [Full Text] [PDF] |
||||
![]() |
P. Korge, H. M. Honda, and J. N. Weiss Protection of cardiac mitochondria by diazoxide and protein kinase C: Implications for ischemic preconditioning PNAS, March 5, 2002; 99(5): 3312 - 3317. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, A. K. S. Camara, J. An, M. L. Riess, E. Novalija, and D. F. Stowe Cardiac preconditioning with 4-h, 17{degrees}C ischemia reduces [Ca2+]i load and damage in part via KATP channel opening Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1961 - H1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Minners, L. Lacerda, J. McCarthy, J. J. Meiring, D. M. Yellon, and M. N. Sack Ischemic and Pharmacological Preconditioning in Girardi Cells and C2C12 Myotubes Induce Mitochondrial Uncoupling Circ. Res., October 26, 2001; 89(9): 787 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murata, M. Akao, B. O'Rourke, and E. Marban Mitochondrial ATP-Sensitive Potassium Channels Attenuate Matrix Ca2+ Overload During Simulated Ischemia and Reperfusion: Possible Mechanism of Cardioprotection Circ. Res., November 9, 2001; 89(10): 891 - 898. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |